Evidence map›Paper›PMID 39679613›Full record

ArticleAnalytical chemistry2024

Improving Glycoproteomic Analysis Workflow by Systematic Evaluation of Glycopeptide Enrichment, Quantification, Mass Spectrometry Approach, and Data Analysis Strategies.

Zhenyu Sun, T Mamie Lih, Jongmin Woo, Liyuan Jiao, Yingwei Hu, Yuefan Wang, Hongyi Liu, Hui Zhang

Abstract read
In one paragraph

Article in Analytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Funding

Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High PrecisionU24CA271079 · NCI · JOHNS HOPKINS UNIVERSITY · PI DANIEL Wanyui CHAN, Hui Zhang · 2022 to 2026
$6.6M
Biomarker Reference LaboratoryU2CCA271895 · NCI · JOHNS HOPKINS UNIVERSITY · PI DANIEL Wanyui CHAN · 2023 to 2026
$4.6M
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesionsU01CA274514 · NCI · JOHNS HOPKINS UNIVERSITY · PI Randall Brand, DANIEL Wanyui CHAN · 2023 to 2026
$3.2M
NCI NIH HHS U01 CA274514NCI NIH HHS U24 CA271079NCI NIH HHS U2C CA271895
6 · The paper itself

Abstract

Glycosylation is one of the most prevalent and crucial protein modifications. Quantitative site-specific characterization of glycosylation usually requires sophisticated intact glycopeptide analysis using glycoproteomics. Recent efforts have focused on the interrogation of intact glycopeptide analyses using tandem mass spectrometry. However, a systematic evaluation of the quantitative glycoproteomic workflow is still lacking. This study compared different strategies for glycopeptide enrichment alongside glycopeptide quantitation, as well as mass spectrometry and data analysis strategies, providing a comprehensive assessment of their efficacy. The ZIC-HILIC enrichment method demonstrated superior performance, representing a 26% improvement in identified glycopeptiudes compared to the MAX enrichment method. Quantification using TMT provided high precision and throughput with an average CV of 8%. Through systematic evaluation, this study established that the ZIC-HILIC enrichment method, quantification with TMT, and collision energies of 25, 35, and 45 using tandem mass spectrometry are the optimal workflow for higher-energy collisional dissociation (HCD) fragmentation, significantly enhancing the analysis of intact glycopeptides. Precise energy adjustment is crucial for the identification of certain glycans. Intact glycopeptides were analyzed using different software tools to investigate the identification and quantification of glycopeptides. By applying optimal settings, 5514 unique intact glycopeptides were in luminal and basal patient-derived xenograft (PDX) characterized models, highlighting distinct glycosylation profiles that may influence tumor behavior. This study offers a systematic approach to evaluate glycoproteomic analysis workflow.

Indexed as

GlycopeptidesProteomicsAnimalsData AnalysisGlycosylationHumansMiceTandem Mass SpectrometryWorkflowGlycopeptides

Identifiers

PMID39679613
PMCPMC12039365

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.